AIMS: Nitrated fatty acids (NO(2)-FA) have been identified as endogenous anti-inflammatory signalling mediators generated by oxidative inflammatory reactions. Herein the in vivo generation of nitro-oleic acid (OA-NO(2)) and nitro-linoleic acid (LNO(2)) was measured in a murine model of myocardial ischaemia and reperfusion (I/R) and the effect of exogenous administration of OA-NO(2) on I/R injury was evaluated. METHODS AND RESULTS: In C57/BL6 mice subjected to 30 min of coronary artery ligation, endogenous OA-NO(2) and LNO(2) formation was observed after 30 min of reperfusion, whereas no NO(2)-FA were detected in sham-operated mice and mice with myocardial infarction without reperfusion. Exogenous administration of 20 nmol/g body weight OA-NO(2) during the ischaemic episode induced profound protection against I/R injury with a 46% reduction in infarct size (normalized to area at risk) and a marked preservation of left ventricular function as assessed by transthoracic echocardiography, compared with vehicle-treated mice. Administration of OA-NO(2) inhibited activation of the p65 subunit of nuclear factor kappaB (NFkappaB) in I/R tissue. Experiments using the NFkappaB inhibitor pyrrolidinedithiocarbamate also support that protection lent by OA-NO(2) was in part mediated by inhibition of NFkappaB. OA-NO(2) inhibition of NFkappaB activation was accompanied by suppression of downstream intercellular adhesion molecule 1 and monocyte chemotactic protein 1 expression, neutrophil infiltration, and myocyte apoptosis. CONCLUSION: This study reveals the de novo generation of fatty acid nitration products in vivo and reveals the anti-inflammatory and potential therapeutic actions of OA-NO(2) in myocardial I/R injury.
AIMS: Nitrated fatty acids (NO(2)-FA) have been identified as endogenous anti-inflammatory signalling mediators generated by oxidative inflammatory reactions. Herein the in vivo generation of nitro-oleic acid (OA-NO(2)) and nitro-linoleic acid (LNO(2)) was measured in a murine model of myocardial ischaemia and reperfusion (I/R) and the effect of exogenous administration of OA-NO(2) on I/R injury was evaluated. METHODS AND RESULTS: In C57/BL6 mice subjected to 30 min of coronary artery ligation, endogenous OA-NO(2) and LNO(2) formation was observed after 30 min of reperfusion, whereas no NO(2)-FA were detected in sham-operated mice and mice with myocardial infarction without reperfusion. Exogenous administration of 20 nmol/g body weight OA-NO(2) during the ischaemic episode induced profound protection against I/R injury with a 46% reduction in infarct size (normalized to area at risk) and a marked preservation of left ventricular function as assessed by transthoracic echocardiography, compared with vehicle-treated mice. Administration of OA-NO(2) inhibited activation of the p65 subunit of nuclear factor kappaB (NFkappaB) in I/R tissue. Experiments using the NFkappaB inhibitor pyrrolidinedithiocarbamate also support that protection lent by OA-NO(2) was in part mediated by inhibition of NFkappaB. OA-NO(2) inhibition of NFkappaB activation was accompanied by suppression of downstream intercellular adhesion molecule 1 and monocyte chemotactic protein 1 expression, neutrophil infiltration, and myocyte apoptosis. CONCLUSION: This study reveals the de novo generation of fatty acid nitration products in vivo and reveals the anti-inflammatory and potential therapeutic actions of OA-NO(2) in myocardial I/R injury.
Authors: Carlos Batthyany; Francisco J Schopfer; Paul R S Baker; Rosario Durán; Laura M S Baker; Yingying Huang; Carlos Cerveñansky; Bruce P Branchaud; Bruce A Freeman Journal: J Biol Chem Date: 2006-05-08 Impact factor: 5.157
Authors: Taixing Cui; Francisco J Schopfer; Jifeng Zhang; Kai Chen; Tomonaga Ichikawa; Paul R S Baker; Carlos Batthyany; Balu K Chacko; Xu Feng; Rakesh P Patel; Anupam Agarwal; Bruce A Freeman; Yuqing E Chen Journal: J Biol Chem Date: 2006-08-03 Impact factor: 5.157
Authors: Marcienne M Wright; Francisco J Schopfer; Paul R S Baker; Vijay Vidyasagar; Pam Powell; Phil Chumley; Karen E Iles; Bruce A Freeman; Anupam Agarwal Journal: Proc Natl Acad Sci U S A Date: 2006-03-06 Impact factor: 11.205
Authors: Laura M S Baker; Paul R S Baker; Franca Golin-Bisello; Francisco J Schopfer; Mitchell Fink; Steven R Woodcock; Bruce P Branchaud; Rafael Radi; Bruce A Freeman Journal: J Biol Chem Date: 2007-08-25 Impact factor: 5.157
Authors: Luis Villacorta; Jifeng Zhang; Minerva T Garcia-Barrio; Xi-lin Chen; Bruce A Freeman; Yuqing E Chen; Taixing Cui Journal: Am J Physiol Heart Circ Physiol Date: 2007-04-27 Impact factor: 4.733
Authors: Bruno B Queliconi; Andrew P Wojtovich; Sergiy M Nadtochiy; Alicia J Kowaltowski; Paul S Brookes Journal: Biochim Biophys Acta Date: 2010-11-20
Authors: Gustavo Bonacci; Eliana K Asciutto; Steven R Woodcock; Sonia R Salvatore; Bruce A Freeman; Francisco J Schopfer Journal: J Am Soc Mass Spectrom Date: 2011-07-13 Impact factor: 3.109
Authors: Gabriela Ambrozova; Hana Martiskova; Adolf Koudelka; Thorben Ravekes; Tanja K Rudolph; Anna Klinke; Volker Rudolph; Bruce A Freeman; Steven R Woodcock; Lukas Kubala; Michaela Pekarova Journal: Free Radic Biol Med Date: 2015-11-24 Impact factor: 7.376
Authors: Antonio D'Amore; Marco Fazzari; Hong-Bin Jiang; Samuel K Luketich; Michael E Luketich; Richard Hoff; Daniel L Jacobs; Xinzhu Gu; Stephen F Badylak; Bruce A Freeman; William R Wagner Journal: Tissue Eng Part A Date: 2018-02-27 Impact factor: 3.845
Authors: Anna Klinke; Annika Möller; Michaela Pekarova; Thorben Ravekes; Kai Friedrichs; Matthias Berlin; Katrin M Scheu; Lukas Kubala; Hana Kolarova; Gabriela Ambrozova; Ralph T Schermuly; Steven R Woodcock; Bruce A Freeman; Stephan Rosenkranz; Stephan Baldus; Volker Rudolph; Tanja K Rudolph Journal: Am J Respir Cell Mol Biol Date: 2014-07 Impact factor: 6.914